Genetic and nongenetic risk factors for childhood cancer

Pediatric Clinics of North America

Volumn 62, Issue 1, 2015, Pages 11-25

  Spector, Logan G ^a   Pankratz, Nathan ^b   Marcotte, Erin L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Case control studies; Epidemiology; Etiology; Genome wide association studies; Pediatric cancer

Indexed keywords

BIRTH WEIGHT; CANCER RISK; CAUSAL ATTRIBUTION; CHILDHOOD CANCER; CONGENITAL MALFORMATION; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; PARENTAL AGE; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; CHILD; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; NEOPLASMS; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEOPLASMS; RISK FACTORS;

EID: 84915746221     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2014.09.013     Document Type: Review

References (86)

1. Howlader N., Noone A.M., Krapcho M., et al. SEER cancer statistics review, 1975-2011 2014, National Cancer Institute, Bethesda (MD).
2. Steliarova-Foucher E., Stiller C., Lacour B., et al. International Classification of Childhood Cancer, third edition. Cancer 2005, 103(7):1457-1467.
3. Wacholder S. Design issues in case-control studies. Stat Methods Med Res 1995, 4(4):293-309.
4. Hawkins M.M., Wilson L.M., Stovall M.A., et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ 1992, 304(6832):951-958.
5. Pui C.H., Relling M.V. Topoisomerase II inhibitor-related acute myeloid leukaemia. Br J Haematol 2000, 109(1):13-23.
6. Tucker M.A., Meadows A.T., Boice J.D., et al. Leukemia after therapy with alkylating agents for childhood cancer. JNatl Cancer Inst 1987, 78(3):459-464.
7. Ron E., Modan B., Boice J.D., et al. Tumors of the brain and nervous system after radiotherapy in childhood. NEngl J Med 1988, 319(16):1033-1039.
8. Cheng J., Su H., Zhu R., et al. Maternal coffee consumption during pregnancy and risk of childhood acute leukemia: a metaanalysis. Am J Obstet Gynecol 2014, 210(2):151.e1-151.e10.
9. Goh Y.I., Bollano E., Einarson T.R., et al. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Clin Pharmacol Ther 2007, 81(5):685-691.
10. Klimentopoulou A., Antonopoulos C.N., Papadopoulou C., et al. Maternal smoking during pregnancy and risk for childhood leukemia: a nationwide case-control study in Greece and meta-analysis. Pediatr Blood Cancer 2012, 58(3):344-351.
11. Latino-Martel P., Chan D.S., Druesne-Pecollo N., et al. Maternal alcohol consumption during pregnancy and risk of childhood leukemia: systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010, 19(5):1238-1260.
12. Milne E., Greenop K.R., Scott R.J., et al. Parental prenatal smoking and risk of childhood acute lymphoblastic leukemia. Am J Epidemiol 2012, 175(1):43-53.
13. Urayama K.Y., Buffler P.A., Gallagher E.R., et al. Ameta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol 2010, 39(3):718-732.
14. Wigle D.T., Turner M.C., Krewski D. Asystematic review and meta-analysis of childhood leukemia and parental occupational pesticide exposure. Environ Health Perspect 2009, 117(10):1505-1513.
15. Zhao L., Liu X., Wang C., et al. Magnetic fields exposure and childhood leukemia risk: a meta-analysis based on 11,699 cases and 13,194 controls. Leuk Res 2014, 38(3):269-274.
16. Kinlen L. Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet 1988, 2(8624):1323-1327.
17. Kinlen L.J. An examination, with a meta-analysis, of studies of childhood leukaemia in relation to population mixing. Br J Cancer 2012, 107(7):1163-1168.
18. Greaves M.F. Aetiology of acute leukaemia. Lancet 1997, 349(9048):344-349.
19. Greaves M.F. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia 1988, 2(2):120-125.
20. Roman E., Simpson J., Ansell P., et al. Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS. Eur J Cancer 2005, 41(5):749-759.
21. Jourdan-Da Silva N., Perel Y., Mechinaud F., et al. Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer 2004, 90(1):139-145.
22. Dockerty J.D., Draper G., Vincent T., et al. Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. Int J Epidemiol 2001, 30(6):1428-1437.
23. Gilham C., Peto J., Simpson J., et al. Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study. BMJ 2005, 330(7503):1294.
24. Neglia J.P., Linet M.S., Shu X.O., et al. Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2000, 82(1):234-240.
25. Infante-Rivard C., Fortier I., Olson E. Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia. Br J Cancer 2000, 83(11):1559-1564.
26. van Steensel-Moll H.A., Valkenburg H.A., van Zanen G.E. Childhood leukemia and infectious diseases in the first year of life: a register-based case-control study. Am J Epidemiol 1986, 124(4):590-594.
27. Dockerty J.D., Skegg D.C., Elwood J.M., et al. Infections, vaccinations, and the risk of childhood leukaemia. Br J Cancer 1999, 80(9):1483-1489.
28. Kwan M.L., Buffler P.A., Abrams B., et al. Breastfeeding and the risk of childhood leukemia: a meta-analysis. Public Health Rep 2004, 119(6):521-535.
29. Van Maele-Fabry G., Lantin A.C., Hoet P., et al. Residential exposure to pesticides and childhood leukaemia: a systematic review and meta-analysis. Environ Int 2011, 37(1):280-291.
30. Turner M.C., Wigle D.T., Krewski D. Residential pesticides and childhood leukemia: a systematic review and meta-analysis. Environ Health Perspect 2010, 118(1):33-41.
31. Rull R.P., Gunier R., Von Behren J., et al. Residential proximity to agricultural pesticide applications and childhood acute lymphoblastic leukemia. Environ Res 2009, 109(7):891-899.
32. Reynolds P., Von Behren J., Gunier R.B., et al. Agricultural pesticide use and childhood cancer in California. Epidemiology 2005, 16(1):93-100.
33. Reynolds P., Von Behren J., Gunier R.B., et al. Childhood cancer and agricultural pesticide use: an ecologic study in California. Environ Health Perspect 2002, 110(3):319-324.
34. Rull R.P., Ritz B. Historical pesticide exposure in California using pesticide use reports and land-use surveys: an assessment of misclassification error and bias. Environ Health Perspect 2003, 111(13):1582-1589.
35. Hjalgrim L.L., Westergaard T., Rostgaard K., et al. Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemiol 2003, 158(8):724-735.
36. Harder T., Plagemann A., Harder A. Birth weight and subsequent risk of childhood primary brain tumors: a meta-analysis. Am J Epidemiol 2008, 168(4):366-373.
37. Harder T., Plagemann A., Harder A. Birth weight and risk of neuroblastoma: a meta-analysis. Int J Epidemiol 2010, 39(3):746-756.
38. Chu A., Heck J.E., Ribeiro K.B., et al. Wilms' tumour: a systematic review of risk factors and meta-analysis. Paediatr Perinat Epidemiol 2010, 24(5):449-469.
39. Milne E., Greenop K.R., Metayer C., et al. Fetal growth and childhood acute lymphoblastic leukemia: findings from the childhood leukemia international consortium. Int J Cancer 2013, 133(12):2968-2979.
40. Caughey R.W., Michels K.B. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer 2009, 124(11):2658-2670.
41. Spector L.G., Puumala S.E., Carozza S.E., et al. Cancer risk among children with very low birth weights. Pediatrics 2009, 124(1):96-104.
42. Ross J.A., Perentesis J.P., Robison L.L., et al. Big babies and infant leukemia: a role for insulin-like growth factor-1?. Cancer Causes Control 1996, 7(5):553-559.
43. Lunde A., Melve K.K., Gjessing H.K., et al. Genetic and environmental influences on birth weight, birth length, head circumference, and gestational age by use of population-based parent-offspring data. Am J Epidemiol 2007, 165(7):734-741.
44. Turcotte L.M., Georgieff M.K., Ross J.A., et al. Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: A report from the Children's Oncology Group. Pediatr Blood Cancer 2014, 61:2018-2023.
45. Johnson K.J., Carozza S.E., Chow E.J., et al. Parental age and risk of childhood cancer: a pooled analysis. Epidemiology 2009, 20(4):475-483.
46. Veltman J.A., Brunner H.G. De novo mutations in human genetic disease. Nat Rev Genet 2012, 13(8):565-575.
47. Botto L.D., Flood T., Little J., et al. Cancer risk in children and adolescents with birth defects: a population-based cohort study. PLoS One 2013, 8(7):e69077.
48. Carozza S.E., Langlois P.H., Miller E.A., et al. Are children with birth defects at higher risk of childhood cancers?. Am J Epidemiol 2012, 175(12):1217-1224.
49. Fisher P.G., Reynolds P., Von Behren J., et al. Cancer in children with nonchromosomal birth defects. JPediatr 2012, 160(6):978-983.
50. Hobbs C.A., Chowdhury S., Cleves M.A., et al. Genetic epidemiology and nonsyndromic structural birth defects: from candidate genes to epigenetics. JAMA Pediatr 2014, 168(4):371-377.
51. Malkin D. Li-Fraumeni syndrome. Genes Cancer 2011, 2(4):475-484.
52. Seif A.E. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis. Cancer Genet 2011, 204(5):227-244.
53. Ross J.A., Spector L.G., Robison L.L., et al. Epidemiology of leukemia in children with Down syndrome. Pediatr Blood Cancer 2005, 44(1):8-12.
54. DeBaun M.R., Tucker M.A. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. JPediatr 1998, 132(3 Pt 1):398-400.
55. Choong S.S., Latiff Z.A., Mohamed M., et al. Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations. Clin Genet 2012, 82(6):564-568.
56. Christensen K., Murray J.C. What genome-wide association studies can do for medicine. NEngl J Med 2007, 356(11):1094-1097.
57. Papaemmanuil E., Hosking F.J., Vijayakrishnan J., et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009, 41(9):1006-1010.
58. Trevino L.R., Yang W., French D., et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009, 41(9):1001-1005.
59. Xu H., Yang W., Perez-Andreu V., et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. JNatl Cancer Inst 2013, 105(10):733-742.
60. Sherborne A.L., Hosking F.J., Prasad R.B., et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet 2010, 42(6):492-494.
61. Ellinghaus E., Stanulla M., Richter G., et al. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 2012, 26(5):902-909.
62. Perez-Andreu V., Roberts K.G., Harvey R.C., et al. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet 2013, 45(12):1494-1498.
63. Migliorini G., Fiege B., Hosking F.J., et al. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Blood 2013, 122(19):3298-3307.
64. Bosse K.R., Diskin S.J., Cole K.A., et al. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. Cancer Res 2012, 72(8):2068-2078.
65. Capasso M., Devoto M., Hou C., et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat Genet 2009, 41(6):718-723.
66. Capasso M., Diskin S.J., Totaro F., et al. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility. Carcinogenesis 2013, 34(3):605-611.
67. Diskin S.J., Capasso M., Diamond M., et al. Rare variants in TP53 and susceptibility to neuroblastoma. JNatl Cancer Inst 2014, 106(4):dju047.
68. Diskin S.J., Capasso M., Schnepp R.W., et al. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nat Genet 2012, 44(10):1126-1130.
69. Diskin S.J., Hou C., Glessner J.T., et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature 2009, 459(7249):987-991.
70. Latorre V., Diskin S.J., Diamond M.A., et al. Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans. Cancer Epidemiol Biomarkers Prev 2012, 21(4):658-663.
71. Maris J.M., Mosse Y.P., Bradfield J.P., et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. NEngl J Med 2008, 358(24):2585-2593.
72. Nguyen le B., Diskin S.J., Capasso M., et al. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility loci. PLoS Genet 2011, 7(3):e1002026.
73. Wang K., Diskin S.J., Zhang H., et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 2011, 469(7329):216-220.
74. Turnbull C., Perdeaux E.R., Pernet D., et al. Agenome-wide association study identifies susceptibility loci for Wilms tumor. Nat Genet 2012, 44(6):681-684.
75. Savage S.A., Mirabello L., Wang Z., et al. Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet 2013, 45(7):799-803.
76. Postel-Vinay S., Veron A.S., Tirode F., et al. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 2012, 44(3):323-327.
77. Raynor L.A., Pankratz N., Spector L.G. An analysis of measures of effect size by age of onset in cancer genomewide association studies. Genes Chromosomes Cancer 2013, 52(9):855-859.
78. Marigorta U.M., Navarro A. High trans-ethnic replicability of GWAS results implies common causal variants. PLoS Genet 2013, 9(6):e1003566.
79. Chokkalingam A.P., Hsu L.I., Metayer C., et al. Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control 2013, 24(10):1789-1795.
80. Linabery A.M., Blommer C.N., Spector L.G., et al. ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leuk Res 2013, 37(8):936-942.
81. Enciso-Mora V., Hosking F.J., Sheridan E., et al. Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia 2012, 26(10):2212-2215.
82. Valentine M.C., Linabery A.M., Chasnoff S., et al. Excess congenital non-synonymous variation in leukemia-associated genes in MLL-infant leukemia: a Children's Oncology Group report. Leukemia 2014, 28(6):1235-1241.
83. Spector L.G., Hooten A.J., Ross J.A. Ontogeny of gene expression: a changing environment for malignancy. Cancer Epidemiol Biomarkers Prev 2008, 17(5):1021-1023.
84. Santure A.W., Spencer H.G. Influence of mom and dad: quantitative genetic models for maternal effects and genomic imprinting. Genetics 2006, 173(4):2297-2316.
85. Nousome D., Lupo P.J., Okcu M.F., et al. Maternal and offspring xenobiotic metabolism haplotypes and the risk of childhood acute lymphoblastic leukemia. Leuk Res 2013, 37(5):531-535.
86. Lupo P.J., Nousome D., Kamdar K.Y., et al. Acase-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 2012, 23(11):1797-1803.